Levamisole-Adulterated Cocaine: A Case Series

References

1. 1.↵
   Centers for Disease Control and Prevention. Agranulocytosis associated with cocaine use–four states, March 2008–November 2009. MMWR Morb Mortal Wkly Rep 2009;58:1381–5.

   OpenUrlPubMed
2. 2.↵
   1. Gross R,
   2. Brucker J,
   3. Bahce-Altuntas A,
   4. et al

   . A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine. Clin Rheumatol 2011;30:1385–92.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Chung C,
   2. Tumeh P,
   3. Birnbaum R,
   4. et al

   . Characteristic purpura of the ears, vasculitis, and neutropenia—a potential public health epidemic associated with levamisole-adulterated cocaine. J Am Acad Dermatol 2011;65:722–5.

   OpenUrlPubMed
4. 4.↵
   1. Geller L,
   2. Whang T,
   3. Mercer S,
   4. Phelps R

   . Retiform purpura: a new stigmata of illicit drug use? Dermatology Online J 2011;17:7.

   OpenUrl
5. 5.↵
   1. Waller J,
   2. Feramisco J,
   3. Alberta-Wszolek L,
   4. McCalmont T,
   5. Fox L

   . Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit? J Am Acad Dermatol 2010;63:530–5.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Ullrich K,
   2. Koval R,
   3. Koval E,
   4. Bapoje S,
   5. Hirsh J

   . Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. J Clin Rheum 2011;17:193–6.

   OpenUrl
7. 7.↵
   1. Valentino A,
   2. Fuentecilla K

   . Levamisole: an analytical profile. Microgram J 2005;3:134–7.

   OpenUrl
8. 8.↵
   1. Buchanan J,
   2. Heard K,
   3. Burbach C,
   4. Wilson M,
   5. Dart R

   . Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital. JAMA 2011;305:1657–8.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Chang A,
   2. Osterloh J,
   3. Thomas J

   . Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther 2010;88:408–11.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Kiley B

    . The mystery of the tainted cocaine. The Stranger 2010 August 17. Available from: http://www.thestranger.com/seattle/Content?mode=print&oid=4683741. Accessed May 7, 2012.
11. 11.↵
    1. MacFarlane D,
    2. Bacon P

    . Levamisole-induced vasculitis due to circulating immune complexes. BMJ 1978;1:407–8.

    OpenUrlFREE Full Text
12. 12.↵
    1. Scheinberg M,
    2. Bezerra J,
    3. Almeida F,
    4. Silveira L

    . Cutaneous necrotising vasculitis induced by levamisole. BMJ 1978;1:408.

    OpenUrlFREE Full Text
13. 13.↵
    1. Rongioletti F,
    2. Ghio L,
    3. Ginevri F,
    4. et al

    . Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 1999;140:948–51.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Czuchlewski D,
    2. Brackney M,
    3. Ewers C,
    4. et al

    . Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol 2010;133:466–72.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Kouassi E,
    2. Caille G,
    3. Lery L,
    4. Lariviere L,
    5. Vezina M

    . Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm Drug Dispos 1986;7:71–89.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Lynch K,
    2. Dominy S,
    3. Graf J,
    4. Kral A

    . Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry. J Analytical Toxicol 2011;35:176–8.

    OpenUrl